Intercept Pharmaceuticals is a leading biopharmaceutical company focused on developing and commercializing innovative therapies for rare and serious liver diseases. The company is dedicated to advancing the understanding and treatment of liver conditions through rigorous research and development efforts. With a commitment to improving patient outcomes, Intercept Pharmaceuticals emphasizes collaboration, technical expertise, and adherence to high standards in its statistical programming and clinical trial processes.